Non-medical Switching of Infliximab to CT-P13 Biosimilar in Inflammatory Bowel Disease: A Focus on the Definition of "Non-medical Switch"

Dig Dis Sci. 2020 Sep;65(9):2737-2738. doi: 10.1007/s10620-020-06423-y. Epub 2020 Jun 26.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal
  • Biosimilar Pharmaceuticals*
  • Humans
  • Inflammatory Bowel Diseases* / drug therapy
  • Infliximab / adverse effects

Substances

  • Antibodies, Monoclonal
  • Biosimilar Pharmaceuticals
  • CT-P13
  • Infliximab